Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Pulmicort + Theophylline in Japanese Asthma Patients
NCT00252785Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Morning Peak Expiratory Flow at 8 weeks. Started Oct 2005; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00252785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252785.